Evidence map›Paper›PMID 34445346›Full record

ArticleInternational journal of molecular sciences2021

Modulating the ERK1/2-MMP1 Axis through Corosolic Acid Inhibits Metastasis of Human Oral Squamous Cell Carcinoma Cells.

Jen-Liang Chen, Chung-Yu Lai, Tsung-Ho Ying, Chiao-Wen Lin, Pei-Han Wang, Fang-Jung Yu, Chung-Jung Liu, Yi-Hsien Hsieh

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jen-Liang ChenDepartment of Hematology & Oncology, Chung-Kang Branch, Cheng Ching Hospital, Taichung 40764, Taiwan.
Chung-Yu LaiDirector of Surgery Department, Chung-Kang Branch, Cheng Ching General Hospital, Taichung 40764, Taiwan.
Tsung-Ho YingDepartment of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
Chiao-Wen LinInstitute of Oral Sciences, Chung Shan Medical University, Taichung 40201, Taiwan.
Pei-Han WangInstitute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Fang-Jung YuDivision of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Chung-Jung LiuDivision of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.ORCID 0000-0002-2657-565X
Yi-Hsien HsiehInstitute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.ORCID 0000-0003-4942-1888
Cheng Ching Hospital · TWChung Shan Medical University · TWChung Shan Medical University Hospital · TWKaohsiung Medical University · TW

Funding

Chung-Kang Branch, Cheng-Ching General Hospital Research Fund CH10900245AKaohsiung Medical University Hospital KMUH109-M901Kaohsiung Medical University Research Center Grant KMU-TC109A02-3
6 · The paper itself

Abstract

Corosolic acid (CA; 2α-hydroxyursolic acid) is a natural pentacyclic triterpenoid with antioxidant, antitumour and antimetastatic activities against various tumour cells during tumourigenesis. However, CA's antitumour effect and functional roles on human oral squamous cell carcinoma (OSCC) cells are utterly unknown. In this study, our results demonstrated that CA significantly exerted an inhibitory effect on matrix metalloproteinase (MMP)1 expression, cell migration and invasion without influencing cell growth or the cell cycle of human OSCC cells. The critical role of MMP1 was confirmed using the GEPIA database and showed that patients have a high expression of MMP1 and have a shorter overall survival rate, confirmed on the Kaplan-Meier curve assay. In the synergistic inhibitory analysis, CA and siMMP1 co-treatment showed a synergically inhibitory influence on MMP1 expression and invasion of human OSCC cells. The ERK1/2 pathway plays an essential role in mediating tumour progression. We found that CA significantly inhibits the phosphorylation of ERK1/2 dose-dependently. The ERK1/2 pathway played an essential role in the CA-mediated downregulation of MMP1 expression and in invasive motility in human OSCC cells. These findings first demonstrated the inhibitory effects of CA on OSCC cells' progression through inhibition of the ERK1/2-MMP1 axis. Therefore, CA might represent a novel strategy for treating OSCC.

Indexed as

Carcinoma, Squamous CellCell MovementCell ProliferationCell SurvivalDown-RegulationDrug Screening Assays, AntitumorHead and Neck NeoplasmsHumansMAP Kinase Signaling SystemMatrix Metalloproteinase 1Mouth NeoplasmsNeoplasm MetastasisSquamous Cell Carcinoma of Head and NeckTriterpenesTumor Cells, Culturedcorosolic acidMatrix Metalloproteinase 1MMP1 protein, humanTriterpenescorosolic acidERK1/2human oral squamous cell carcinoma cellsmetastasisMMP1

Identifiers

PMID34445346
PMCPMC8395509
OpenAlexW3189840496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.